FNY Managed Accounts’s iShares Biotechnology ETF IBB Stock Holding History

FNY Managed Accounts’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,400	Closed	-$469K	–	700
2017 Q4	$469K	Buy	+4,400	New	+$470K	0.43%	21
2017 Q3	–	Sell	-165	Closed	-$17K	–	634
2017 Q2	$17K	Sell	165 -144	-47%	-$14.2K	0.17%	81
2017 Q1	$30K	Buy	+309	New	+$29.6K	0.09%	298
2016 Q3	–	Sell	-300	Closed	-$28.5K	–	469
2016 Q2	$25.7K	Sell	300 -273	-48%	-$24.5K	0.02%	154
2016 Q1	$49.8K	Buy	+573	New	+$51.2K	0.09%	139
2015 Q4	–	Sell	-4,665	Closed	-$472K	–	273
2015 Q3	$472K	Buy	+4,665	New	+$560K	1.32%	15
2014 Q2	–	Sell	-3,600	Closed	-$284K	–	122
2014 Q1	$284K	Buy	+3,600	New	+$300K	0.75%	19

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FNY Managed Accounts's IBB Position: Q1 2018 in Review

FNY Managed Accounts sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 4,400 shares — an estimated $469K sold.

FNY Managed Accounts first reported a position in IBB in Q1 2014 and held it in 7 quarters. The position peaked at $472K in Q3 2015. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

FNY Managed Accounts reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 4,400 iShares Biotechnology ETF shares in Q1 2018, an estimated $469K.
FNY Managed Accounts first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 7 quarters.
FNY Managed Accounts's iShares Biotechnology ETF position peaked at $472K in Q3 2015.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.